tiprankstipranks
Trending News
More News >
BridgeBio Oncology Therapeutics (BBOT)
NASDAQ:BBOT
US Market

BridgeBio Oncology Therapeutics (BBOT) Cash flow

Compare
21 Followers

BridgeBio Oncology Therapeutics Cash Flow

BBOT's free cash flow for Q3 2025 was $-71.16M. For the 2025 fiscal year, BBOT's free cash flow was decreased by $-763.82K and operating cash flow was $-70.63M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -763.82K$ 0.00$ 0.00$ 0.00$ -316.69K
Investing Cash Flow
$ -184.00M$ 0.00$ 0.00$ 0.00$ -115.00M
Financing Cash Flow
$ 186.46M$ 0.00$ 0.00$ 0.00$ 116.65M
End Cash Position
$ 1.70M$ 0.00$ 0.00$ 0.00$ 1.34M
Free Cash Flow
$ -763.82K$ 0.00$ 0.00$ 0.00$ -316.69K
Currency in USD

BridgeBio Oncology Therapeutics Cash Flow